Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 21, 2025
Long COVID: Is mitochondria the target?
Bernat Soria, Etelvina Andreu, Aitor Gonzaga
American Journal of Physiology. Endocrinology and Metabolism
|
January 9, 2003
On-line analysis of gap junctions reveals more efficient electrical than dye coupling between islet cells
Ivan Quesada, Esther Fuentes, Etelvina Andreu, et al.
International Journal of Molecular Sciences
|
December 23, 2023
Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?
Bernat Soria, Natalia Escacena, Aitor Gonzaga, et al.
Biomedicines
|
August 28, 2025
Non-Viral Therapy in COVID-19: Where Are We Standing? How Our Experience with COVID May Help Us Develop Cell Therapies for Long COVID Patients
Aitor Gonzaga, Gema Martinez-Navarrete, Loreto Macia, et al.
Frontiers in Immunology
|
February 26, 2021
Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration After Snakebite Envenoming
E Eduardo Sanchez-Castro, Cecilia Pajuelo-Reyes, Rebeca Tejedo, et al.
Eclinicalmedicine
|
August 25, 2020
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study
Fermín Sánchez-Guijo, Mariano García-Arranz, Miriam López-Parra, et al.
Stem Cell Research & Therapy
|
April 5, 2025
Consecutive intrabronchial administration of Wharton's jelly-derived mesenchymal stromal cells in ECMO-supported pediatric patients with end-stage interstitial lung disease: a safety and feasibility study (CIBA method)
Nerea Dominguez-Pinilla, Luis Ignacio González-Granado, Aitor Gonzaga, et al.
Trials
|
September 7, 2021
Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)
Barbara Soria-Juan, Mariano Garcia-Arranz, Lucía Llanos Jiménez, et al.
Frontiers in Immunology
|
September 28, 2023
Rationale for combined therapies in severe-to-critical COVID-19 patients
Aitor Gonzaga, Etelvina Andreu, Luis M Hernández-Blasco, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 21, 2025
Long COVID: Is mitochondria the target?
Bernat Soria, Etelvina Andreu, Aitor Gonzaga
American Journal of Physiology. Endocrinology and Metabolism
|
January 9, 2003
On-line analysis of gap junctions reveals more efficient electrical than dye coupling between islet cells
Ivan Quesada, Esther Fuentes, Etelvina Andreu, et al.
International Journal of Molecular Sciences
|
December 23, 2023
Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?
Bernat Soria, Natalia Escacena, Aitor Gonzaga, et al.
Biomedicines
|
August 28, 2025
Non-Viral Therapy in COVID-19: Where Are We Standing? How Our Experience with COVID May Help Us Develop Cell Therapies for Long COVID Patients
Aitor Gonzaga, Gema Martinez-Navarrete, Loreto Macia, et al.
Frontiers in Immunology
|
February 26, 2021
Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration After Snakebite Envenoming
E Eduardo Sanchez-Castro, Cecilia Pajuelo-Reyes, Rebeca Tejedo, et al.
Eclinicalmedicine
|
August 25, 2020
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study
Fermín Sánchez-Guijo, Mariano García-Arranz, Miriam López-Parra, et al.
Stem Cell Research & Therapy
|
April 5, 2025
Consecutive intrabronchial administration of Wharton's jelly-derived mesenchymal stromal cells in ECMO-supported pediatric patients with end-stage interstitial lung disease: a safety and feasibility study (CIBA method)
Nerea Dominguez-Pinilla, Luis Ignacio González-Granado, Aitor Gonzaga, et al.
Trials
|
September 7, 2021
Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)
Barbara Soria-Juan, Mariano Garcia-Arranz, Lucía Llanos Jiménez, et al.
Frontiers in Immunology
|
September 28, 2023
Rationale for combined therapies in severe-to-critical COVID-19 patients
Aitor Gonzaga, Etelvina Andreu, Luis M Hernández-Blasco, et al.
Page
of 1